Support of the Sexual Health in Oncology
Sponsor
Groupe Hospitalier Paris Saint Joseph (Other)
Overall Status
Withdrawn
CT.gov ID
NCT03166774
Collaborator
(none)
0
12
Study Details
Study Description
Brief Summary
Implementation of sexual health support program in oncology department. This program is organized in 3 axes. One is to inform the side effects of treatment on sexual health.
There is a counselling team (nurse, esthetician,sexologue..etc) to raise the subject with patient and partner .
Finally, the oncologist continue during the treatment to evaluate the benefit of this program and adapt their counselling according to the needs
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Study Type:
Observational
Actual Enrollment
:
0 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Support of the Sexual Health in Oncology
Actual Study Start Date
:
Jun 6, 2016
Actual Primary Completion Date
:
Jun 6, 2017
Anticipated Study Completion Date
:
Jun 6, 2017
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
patient consulting in oncology ervice Program of support of the sexual health in oncology by questionnaire |
Other: Program of support of the sexual health
Patients included in the study have to answer to a questionnaire
|
Outcome Measures
Primary Outcome Measures
- Benefit of the care measurement program [Day 1]
assessment of data recorded on questionnaire
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
-
all patient consulting in oncology service
-
age > 18 years
-
accepting to participate
Exclusion Criteria:
-
Age< 18 years
-
Refusing to participate
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Groupe Hospitalier Paris Saint Joseph
Investigators
- Principal Investigator: Alexandra SCHULTZ, Psychologist, Groupe Hospitalier Paris Saint Joseph
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Groupe Hospitalier Paris Saint Joseph
ClinicalTrials.gov Identifier:
NCT03166774
Other Study ID Numbers:
- AssO
First Posted:
May 25, 2017
Last Update Posted:
Aug 9, 2018
Last Verified:
Aug 1, 2018
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: